Comparative Pharmacology
Head-to-head clinical analysis: CHLOROFAIR versus GAMOPHEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLOROFAIR versus GAMOPHEN.
CHLOROFAIR vs GAMOPHEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.
Gamophen contains chlorhexidine gluconate, a cationic bisbiguanide that disrupts microbial cell membranes by binding to negatively charged phosphate groups on bacterial cell walls, leading to leakage of intracellular contents and cell death. It also inhibits bacterial enzymes and has broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, fungi, and some viruses.
125 mg IV every 6 hours for 10 days.
GAMOPHEN is not a recognized pharmaceutical drug. Please verify the drug name.
None Documented
None Documented
4.5 hours (prolonged to 10–12 hours in renal impairment)
Terminal elimination half-life is 18-32 hours in adults, prolonged in renal impairment (up to 60 hours in severe cases).
Renal: 70% unchanged; hepatic metabolism: 25% conjugated; fecal: 5%
Primarily renal excretion of unchanged drug (50-70%) and glucuronide conjugates; biliary/fecal elimination accounts for <10%.
Category C
Category C
Antiseptic
Antiseptic